Osteoporosis Medication and Dementia: New Study | QuickRx

Osteoporosis And Dementia

Could a medicine for weak bones also protect the brain? A large study from the University of Hong Kong found that older adults who took a common group of osteoporosis drugs were less likely to be diagnosed with Alzheimer’s disease or another dementia. Here is what the researchers found, what the study can and cannot tell us, and what it means if you or a loved one takes an osteoporosis medication.

121,492
adults 60+ in the study
16%
lower dementia risk vs. no osteoporosis medicine
24%
lower dementia risk vs. other osteoporosis drugs
48
people treated for 5 years to prevent 1 case

What Did the Osteoporosis and Dementia Study Find?

Researchers looked at the medical records of 121,492 adults aged 60 and older in Hong Kong who had osteoporosis or a fragility fracture between 2005 and 2020. They compared people who took nitrogen-containing bisphosphonates with similar people who took no osteoporosis medication, and with people who took other osteoporosis drugs.

Dementia risk for bisphosphonate users, compared with each group
Compared with no osteoporosis medicine
No osteoporosis medicine: 100
Bisphosphonate users
Bisphosphonates: 84 (16% lower)
Compared with other osteoporosis drugs
Other osteoporosis drugs: 100
Bisphosphonate users
Bisphosphonates: 76 (24% lower)
Relative risk, with the comparison group set at 100. Source: Sing et al., Alzheimer’s & Dementia, 2025 (hazard ratios 0.84 and 0.76).

The lower risk was seen in both women and men, and in people with hip fractures. The study was published in July 2025 in Alzheimer’s & Dementia, the journal of the Alzheimer’s Association.

Which Osteoporosis Drugs Were Studied?

The study focused on nitrogen-containing bisphosphonates, a group of osteoporosis medicines that slow bone loss. About 80% of the people in this group took alendronate.

Studied group: nitrogen-containing bisphosphonates

Alendronate (about 80%)IbandronateRisedronateZoledronate

Comparison group: other osteoporosis drugs

DenosumabSalcatonin (calcitonin)Strontium ranelateTeriparatide (Forteo)

How Big Was the Effect?

The researchers estimated that about 48 people would need to take a bisphosphonate for five years to prevent one case of dementia. For any one person the difference is small, but across a large population of older adults it could add up.

48 people treated for 5 years = 1 dementia case prevented (estimate)
Each circle is one person. The blue circle is the one case the researchers estimate would be prevented.

Does This Mean Bisphosphonates Prevent Dementia?

No. This was an observational study, which means it looked back at medical records. It can show that two things are linked, but it cannot prove that the medication caused the lower dementia risk.

What the study shows
  • Bisphosphonate users had fewer dementia diagnoses
  • The link held in women, men and hip fracture patients
  • Results stayed similar when checked several different ways
What it cannot tell us
  • Whether the drug itself lowered the risk
  • Memory and thinking at the start of the study
  • Bone density, exercise, education or supplements like vitamin D

Clinical trials that assign people to a medication at random are needed before anyone can say these drugs protect the brain.

Why Might Bone Medicines Affect the Brain?

Nitrogen-containing bisphosphonates block an enzyme in the body’s mevalonate pathway, the same pathway that cholesterol-lowering statins act on. Researchers have found higher levels of some products of this pathway in the brains of people with Alzheimer’s disease, and animal studies with alendronate have shown less brain inflammation and less amyloid buildup. These findings point to a possible link, but they have not been confirmed in people.

What About Other Osteoporosis Medications, Like Forteo?

The study grouped several different medicines together as “other osteoporosis drugs,” including teriparatide (Forteo) and denosumab. People who take these medicines often have different health needs, such as more severe osteoporosis, so they cannot be compared directly with bisphosphonate users. This study does not show that any of these medicines raises or lowers the risk of dementia on its own.

What Should Patients Do With This Information?

1. Don’t change your medication. Do not start, stop or switch an osteoporosis medicine based on this study. Each one is chosen for your bone health, fracture risk and medical history.

2. Ask your doctor. Bring this study to your next appointment and ask what it means for you.

3. Keep up brain-healthy habits. Stay active, manage blood pressure and blood sugar, stay socially connected and keep up with regular checkups.

Have questions about your osteoporosis medication or what it costs? A QuickRx patient navigator can help. Call (917) 830-2525.

“Studies like this give you good questions to bring to your next appointment. Your osteoporosis treatment is chosen to protect your bones, so talk with your doctor before making any change.”

Julia Kravtsova, PharmD, Pharmacy Director, QuickRx Specialty Pharmacy

References


Medical Disclaimer: This article is for educational purposes only and does not replace professional medical advice. Do not start, stop or change any osteoporosis medication without talking to your doctor.

Research Disclaimer: The study described here is observational. It shows a link between osteoporosis medications and dementia diagnoses but does not prove that any medication prevents dementia. Results may not apply to every patient or population.

Brand Disclaimer: QuickRx Specialty Pharmacy is not affiliated with, endorsed by or sponsored by any manufacturer named in this article; brand names are used for identification only.

Written by: Paola Larrabure, Marketing Director, QuickRx Specialty Pharmacy

Medically Reviewed by: Julia Kravtsova, PharmD, Pharmacy Director, QuickRx Specialty Pharmacy

Last Updated: November 2026

Contact Form (old)

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Contact

This is to contact our corporate office. If you’re interested in contacting an individual QuickRx pharmacy, please visit our Locations Pages or you can Give Us a Call at the Headquarters (212) 249-8202. If you want immediate specialty pharmacy services please call: (347)-691-3494


Are You a Patient or Provider?